Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)
ConditionNeonatal Jaundice
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-14
SponsorPicterus AS
About this trial
A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.
Eligibility criteria
Qualifiers
Infants born with gestational age > 35 weeks.
Birth weight ≥ 1800 grams
Age 1 - 14 days
Infants requiring a TSB blood sample for clinically suspected jaundice as part of standard care
Disqualifiers
Infants showing signs of inborn disease.
Infants with skin rash or other skin disease that affects the skin where measurements are performed.
Infants transferred to the pediatric ward for medical treatment.
Infants that have received phototherapy in the last 24 hours
Trial design
Treatments tested in this trial
- Picterus Jaundice Pro (JP)
Treatment groups
250 Participants
are divided into 1 treatment groupSponsors and collaborators
Picterus AS
Lead sponsor
University of Chicago
Collaborator
Source ClinicalTrials.gov